About this trial
The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.
Eligibility criteria
Qualifiers
Clinically diagnosed diabetic kidney disease (DKD)
Age 18-80 years
Disqualifiers
Malignant tumor, active infection, or life expectancy <1 year
Pregnancy or lactation
MRE contraindications (metal implants, claustrophobia, severe arrhythmia) or poor image quality
eGFR <15 mL/min/1.73m² or receiving renal replacement therapy
Trial design
Treatments tested in this trial
- Magnetic Resonance Imaging